Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2002-03 | Page 59

### 45. Basic Earnings Per Share (EPS):

The computation of EPS is given below :

| Particulars | Note | 2003 | 2002 |
|---|---|---|---|
| (a) Earnings attributable to the Ordinary Shareholders (Net Profit after Tax) | | 224,643,327 | 341,680,048 |
| (b) Weighted average number of Ordinary Shares outstanding during the year | | 50,887,500 | 50,887,500 |
| (c) Basic EPS of 2003/Adjusted EPS of 2002 Tk. | | 4.41 | 6.71 |

The definition of numerator (Earnings) and denominator (weighted average number of shares) is stated in Note-15.

### 46. Cash flow from Operation Under Indirect Method :

| Particulars | Note | 2003 | 2002 |
|---|---|---|---|
| Net profit after tax for the year | | 224,643,327 | 341,680,048 |
| Adjustment to reconcile net profit to net cash provided by operating activities : | | | |
| (a) Non-Cash Expenses: | | 88,660,558 | 95,980,045 |
| Depreciation | | 84,682,512 | 88,012,675 |
| Gratuity | | 3,978,046 | 7,967,370 |
| (b) (Gain)/ Loss on Sale of Fixed Assets | | 849,124 | (572,508) |
| Bonus Shares of Padma Textile Mills Ltd. | | (2,632,500) | - |
| Fund from Operations before Changes in Working Capital | | 311,520,509 | 437,087,585 |
| (c) Changes in Working Capital | | (152,323,527) | (296,176,229) |
| (Increase)/Decrease in Inventories | | (30,171,523) | 30,780,747 |
| (Increase) in Accounts Receivable | | (52,369,609) | (113,423,572) |
| (Increase) in Loans, Advances & Deposits | | (82,342,405) | (143,273,908) |
| Increase/(Decrease) in Creditors and Other Payables | | 12,453,989 | (94,764,634) |
| Increase in Accrued Expenses | | 6,114,227 | 13,992,056 |
| Increase/(Decrease) in Income Tax Payable | | (6,008,206) | 10,513,082 |
| **Net Cash Provided by Operating Activities** Tk. | | **159,196,982** | **140,911,356** |

### 47. Related Party Transactions :

| Particulars | Note | 2003 | 2002 |
|---|---|---|---|
| (a) Accounts Receivable | | 463,061,601 | 387,549,191 |
| (b) Trade Creditors | | 585,000 | 500,000 |
| (c) Current Account Balances | | - | 58,555,415 |
| (d) Interest Income | | - | 3,068,245 |
| (e) Distribution Commission | | 30,719,966 | 34,520,436 |
| (f) Software & Networking Expenses | | 4,000,000 | 4,400,000 |
| (g) Investment in Shares | | 43,176,250 | 40,543,750 |
| (h) Cash and Stock Dividend Income | | 3,948,750 | 1,316,250 |